Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia
- PMID: 39488662
- DOI: 10.1038/s41375-024-02455-9
Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia
Abstract
The transcription factor MYB is frequently upregulated in T-cell acute lymphoblastic leukemia (T-ALL), a hematological malignancy originating from T-cell precursors. Here, we demonstrate that MYB plays a crucial role by regulating genes essential for T-ALL pathogenesis. Integrative analysis reveals a long MYB isoform, ENST00000367814.8, which is dominantly expressed and confers a proliferative advantage in T-ALL cells. Rapid depletion of MYB via dTAG-mediated protein degradation affects a large number of genes, which can be classified into early response or late response genes based on their kinetics. Early response genes include many genes involved in hematopoiesis, such as TAL1, RUNX1, GATA3, IKZF2, and CXCR4. Their expression can be recovered at later time-points, suggesting the presence of a negative feedback loop mechanism. In contrast, late response genes, which are continuously downregulated after MYB depletion, includes many genes involved in cell proliferation as well as TAL1 targets, thereby affecting the cellular phenotype.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: All methods were performed in accordance with the relevant guidelines and regulations at our institute. This study does not involve any animal models or patient samples and thus does not require ethics approval.
References
-
- Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129:1113–23. - PubMed
-
- Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011;29:551–65. - PubMed
-
- van der Zwet CordoV, Canté-Barrett JCG, Pieters K, Meijerink R. JPP. T-cell acute lymphoblastic leukemia: a roadmap to targeted therapies. Blood Cancer Discov. 2021;2:19–31. - PubMed
-
- Patel AA, Thomas J, Rojek AE, Stock W. Biology and treatment paradigms in T Cell acute lymphoblastic leukemia in older adolescents and adults. Curr Treat Options Oncol. 2020;21:57. - PubMed
-
- Pui C-H, Evans William E. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–78. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases